3 November 2020

Gynaecologist Annemiek Nap has been appointed professor of Reproductive Medicine at Radboud University and Radboudumc with effect from 1 January 2021. In this capacity, Nap will focus on finding solutions to issues in the field of fertility. In addition, she will work on improving the care for women with endometriosis.

Endometriosis

Annemiek Nap (Valburg, 1973) worked at the Rijnstate Hospital in Arnhem from 2009 and focused on the areas of fertility and endometriosis (the presence of endometrium‑like tissue outside of the uterus). There, she established a multidisciplinary centre for diagnostics and treatment of endometriosis.

Annemiek passed her final degree examination in Medicine cum laude in 1999 at Radboud University, obtained her PhD in Maastricht (on the dissertation The pathogenesis of endometriosis: Sampson was right) and remained there to follow training to become a gynaecologist. She is no stranger to the Radboudumc: she was a fellow in Reproductive Medicine at the Radboudumc from 2010 to 2012.

Reproductive Medicine Manual

Through collaborations with various partners, Annemiek Nap has made major contributions to the knowledge in her field. She and her colleagues wrote the Handboek Voortplantingsgeneeskunde (Reproductive Medicine Manual), she is the chair of the Reproductive Medicine pillar of the Dutch Association for Obstetrics and Gynaecology (NVOG), and she was involved in the establishment of the European guideline on the management of women with endometriosis, amongst other accomplishments. She is also a member of the board of the World Endometriosis Society. Through national and international collaborations, she seeks to fill in the gaps in knowledge in the field of gynaecology.

Related news items


Tailored drug dosage for pregnant women

14 March 2022

Three quarters of women in the Netherlands use some form of medication during pregnancy, but little is known about the appropriate dosages. Research by the Radboudumc, MUMC+ and Lareb Mothers of Tomorrow should change this.

read more

New method to prevent ovarian cancer increases quality of life

8 June 2021

Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

Marc Spaanderman appointed Professor of Obstetrics

16 April 2020

Marc Spaanderman has been appointed Professor of Obstetrics at Radboud University/ Radboud university medical center, with effect from 1 March 2020.

read more

Differences in the placental disposition of TNF inhibitors uncovered

19 March 2020

In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.

read more

Plugging the gap ZonMw/Health Holland grant

3 March 2020

RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM).

read more